Thinking up tomorrow's medicine
[Press release] On February 1, the fourth and final call for incentives has opened, offering SMEs the chance to speed up their innovation. Life Sciences SMEs are invited to apply until May 4, 2014. A total of 164 incentives have been granted during the first three calls; 53 Collaboration, 29 Insight, 82 Meet and Greet. SMEs that wish to take part in the project can contact their Regional Access Broker or fill out an online application form.
KORILOG is a publisher of scientific software for sequence data analysis. The company offers a range of software based on KLAST, the new high-performance sequence similarity search technology created by Korilog and the Rennes INRIA1-IRISA2 research center. Through the network of Atlanpole Biotherapies, Korilog wants to accelerate its development by taking part in projects with the network members, both private and academic.
Advanced Accelerator Applications announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE. The orphan drug designation has been granted by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for use of Gallium-68 DOTATATE as a diagnostic agent for the management of Gastro-Entero- Pancreatic Neuroendocrine Tumors (GEP-NETs).
This two-day international workshop features presenta¬tions by leading actors in the field of anti-tumor immunity from academia, industry and biotech companies providing a platform for scientific discussion and launching of colla-borative projects.
The Stern-Forum: "Innovation and Biomaterials" serves as a pathfinder for entrepreneurs and researchers in order to establish upcoming business contacts and collaborations. The event, which will be held in English, is organised in the context of the two EU-projects, nameley Biomat-IN and IN2LifeSciences. This will afford you the opportunity to engage with regional biotechnology, medical technology and other life sciences companies.
You are a French company in the healthcare industry and initiating an innovative project, you want to accelerate your international development by partnering with professionals whose expertise is recognized. On July 11th and 12th, Ubistart, which will be a unique opportunity to create partnerships with North American innovative start-up companies in the health sector, will take place in New York. Attend the free information webinar on April 9th.
Atlanpole Biotherapies, Korilog and Bakasable (two of our companies) will attend this major international conference about the application of informatics, IT and computer science in biomedical research and drug discovery.
An Atlanpole Biotherapies delegation will attend this major international convention on biotechnologies which is taking place in San Diego from the 23rd to the 26th of June.
International Cancer Cluster Showcase will take place June 22nd, 2014 - Bio San Diego
Organised by the European Orthopaedic Research Society, the EORS 2014 meeting will focus on the following special topics: the mechanisms of osteoinduction, osteoimmunology and bone tumors, transferring innovation to clinical practice. 300 people are expected at this conference that offers workshops and presentations by renowned researchers and surgeons.
The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.
Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005).